Psychometric evaluation of a patient-reported symptom assessment tool for adults with haemophilia (the HAEMO-SYM)

Haemophilia

Volumn 15, Issue 5, 2009, Pages 1039-1047

  Rentz, A ^a   Flood, E ^a   Butler, R ^b   Christie, B ^c   Giangrande, P ^d   Mc Cusker, P ^e   Wasserman, J ^f   Gorina, Eduard ^g  

^a UBC   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF TEXAS   (United States)

^g BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; CANADA; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPISTAXIS; FATIGUE; GASTROINTESTINAL HEMORRHAGE; HAEMO SYM; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE FUNCTIONAL DISABILITY INDEX; HEALTH STATUS; HEMARTHROSIS; HEMATURIA; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERNAL CONSISTENCY; JOINT STIFFNESS; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; PSYCHOMETRY; REPRODUCIBILITY; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SYMPTOMATOLOGY; TEST RETEST RELIABILITY; TREATMENT INDICATION; UNITED STATES; VALIDITY;

ACTIVITIES OF DAILY LIVING; ADULT; CANADA; CROSS-CULTURAL COMPARISON; HEMOPHILIA A; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 69949099942     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01955.x     Document Type: Article

References (35)

1. de Joode EW, van Meeteren NL, van den Berg HM, de Kleijn P, Helders PJ. Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia. Haemophilia 2001; 7: 190-7.
2. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
3. Royal S, Schramm W, Berntorp E et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
4. Gilbert MS. Prophylaxis: Musculoskeletal evaluation. Semin Hematol 1993; 30(3 Suppl 2): 3-6.
5. Rentz A, Flood E, Altisent C et al. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality-of-life questionnaire for adults with hemophilia. Haemophilia 2008; 14: 1023-34.
6. Aznar JA, Magallon M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170-6.
7. Chang TJ, Mohamed S, Hambleton J. Hemophilic arthropathy: Considerations in management. J Am Podiatr Med Assoc 2001; 91: 406-14.
8. Iwata N, Hachisuka K, Tanaka S, Naka Y, Ogata H. Measuring activities of daily living among haemophiliacs. Disabil Rehabil 1996; 18: 217-23.
9. Santavirta N, Bjorvell H, Solovieva S, Alaranta H, Hurskainen K, Konttinen YT. Coping strategies, pain, and disability in patients with hemophilia and related disorders. Arthritis Rheum 2001; 45: 48-55.
10. Santavirta N, Solovieva S, Helkama O, Lehto S, Konttinen YT, Santavirta S. Musculoskeletal pain and functional ability in haemophilia A and B. Physiotherapy and rehabilitation in haemophilia patients. Rheumatol Int 2001; 21: 15-9.
11. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001; 7: 53-63.
12. Page MJ. Health-related quality of life in hemophilia: A pilot evaluation. HemAware, 2001; ???: 72-8.
13. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
14. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
15. Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. Haemophilia 2000; 6: 23-32.
16. Szucs TD, Offner A, Schramm W. Socioeconomic impact of haemophilia care: results of a pilot study. Haemophilia 1996; 2: 211-7.
17. Trippoli S, Vaiani M, Linari S, Longo G, Morfini M, Messori A. Multivariate analysis of factors influencing quality of life and utility in patients with haemophilia. Haematologica 2001; 86: 722-8.
18. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
19. Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988; 15: 1480-8.
20. Santavirta N, Bjorvell H, Koivumaki E, Hurskainen K, Solovieva S, Konttinen YT. The factor structure of coping strategies in hemophilia. J Psychosom Res 1996; 40: 617-24.
21. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15.
22. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. Br Med J 1998; 316: 690-3.
23. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994; 47: 81-7.
24. Revicki DA, Irwin D, Reblando J, Simon GE. The accuracy of self-reported disability days. Med Care 1994; 32: 401-4.
25. Aday L. Designing and Conducting Health Surveys, 2nd edn. San Francisco: Jossey-Bass/Pfeiffer, 1996.
26. Hays RD, Anderson RT, Revicki DA. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM, eds. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1998.
27. Nunnally JC. Psychometric Theory, 3rd edn. New York: McGraw-Hill, 1994.
28. Wilde JT, Lee CA, Collins P, Giangrande PL, Winter M, Shiach CR. Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders. Br J Haematol 1999; 107: 556-9.
29. Poonnoose PM, Thomas R, Keshava SN et al. Psychometric analysis of the Functional Independence Score in Haemophilia (FISH). Haemophilia 2007; 13: 620-6.
30. Ekert H, Brewin T, Boey W, Davey P, Tilden D. Cost-utility analysis of recombinant factor VIIa (NovoSeven) in six children with long-standing inhibitors to factor VIII or IX. Haemophilia 2001; 7: 279-85.
31. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
32. Pettersson H, Gilbert MS. Clinical and radiological evaluations of hemophilic arthropathy. In: Pettersson H, Gilbert MS eds. Diagnostic Imaging in Hemophilia. Berlin: Springer-Verlag, 1985: 56-68.
33. Rodriguez-Merchan EC, Wiedel JD, Wallny T et al. Elective orthopaedic surgery for inhibitor patients. Haemophilia 2003; 9: 625-31.
34. Schramm W, Royal S, Kroner B et al. Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia 2002; 8: 33-43.
35. Wallny T, Lahaye L, Brackmann HH, Hess L, Seuser A, Kraft CN. Clinical and radiographic scores in haemophilic arthropathies: How well do these correlate to subjective pain status and daily activities? Haemophilia 2002; 8: 802-8.